Comparing Two Ways to Manage Head and Neck Lymphedema
Status
Conditions
Treatments
Details and patient eligibility
About
This randomized clinical trial aims to compare clinic-based CDT and home-based (a hybrid model) CDT on changes in the severity of lymphedema, symptom burden, functional status, and healthcare utilization in HNC survivors with lymphedema.
Full description
Primary aim: To compare the effects of clinic-based and home-based (a hybrid model) CDT on changes in the severity of lymphedema.
Secondary aim: To compare the effects of clinic-based and home-based (a hybrid model) CDT on symptom burden and functional status.
Exploratory aim: To compare the healthcare utilization between patients receiving clinic-based versus home-based (a hybrid model) CDT
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- >18 years of age
- <=24 months post-HNC treatment
- Diagnosis of head and neck lymphedema and referral by their oncology providers
- Able to perform self-manual lymphatic drainage
- Having an electronic device (a computer, tablet, iPad, laptop, or smartphone) and internet access at home
Exclusion criteria
- Active infection in soft tissues in the head and neck region
- History of moderate or severe carotid artery occlusion
- Significantly severe lymphedema (e.g., severe periorbital swelling)
- Conditions impacting the safe delivery of lymphedema therapy
Trial design
Primary purpose
Allocation
Interventional model
Masking
300 participants in 2 patient groups
Trial contacts and locations
Loading...
Central trial contact
Jie Deng, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal